SARS-CoV-2 Life Cycle

Learn more about the coronavirus life cycle and discover products
to help you in your researches.

Learn more

Genome evolution
of 2019-nCoV

It has been reported that 2 genotypes of SARS-CoV-2 do exist. The S and L types named according to the amino acid 84 (S84L). S and L types can be differentiated by 2 SNPs at positions 8782 (orf1ab: T8517C) and 28144 (ORF8: C251T, S84L). S genotype SARS-CoV-2 is described to be the ancestral version while the L-type evolved from the S-type and seems to have a higher frequency. It is still unclear why L-type is more virulent and how it evolved from the S-type. (4)

A SARS-CoV-2 variant with a 382 nucleotides deletion emerged in Wuhan early in the pandemic. The deletion occurred in ORF7b removing the ORF8 transcription regulatory sequence.


This led to virus attenuation and reduced replication but lead to immune evasion. ORF8 is considered a hotspot for genetic variation. Other variants with a deletion in ORF8 were reported in Bangladesh (345 nucleotides), Australia (138 nucleotides), and Spain (62 nucleotides) (5)

Studies are continuously made to keep identifying the emergence of new variants of SARS-CoV-2. Sequence analysis is a key point to ensure testing efficacy if a change occurs in immune targets or oligonucleotide (primers, probes) binding sites.  

Decipher the SARS CoV codes

Decoding the SARS-CoV-2 genome implies sample collection and analysis.
Viral RNA analysis and phylogenetic studies call for genomic related reagents
such as oligonucleotides, polymerases, and electrophoresis related products.


Choose your weapons

We are experts in the production of oligonucleotides and have a large portfolio of usual and exotic modifications. We offer a large panel of fluorophores and quenchers covering all the qPCR channels. Our Access™ Dyes and Quenchers range offers a class of proprietary molecules or other dyes & quenchers with unmatched detection performance and IP-friendly terms and conditions.

For sequencing purposes, we recommend our NGS custom oligonucleotides specially produced to avoid cross-contamination and reduce barcode misalignment during multiplex next-generation sequencing projects.

RUO Oligonucleotides Configure
Diagnostic Oligonucleotides Request a quote
Therapeutic Oligonucleotides Request a quote
NGS Oligonucleotides Configure
Double-Dye Probes Configure
Molecular Beacons Configure
MGB Probes Configure
Access™ Dyes and Quenchers View our Offer

Small interference RNAs (siRNAs) are potential candidates for anti-SARS drugs. siRNA could be used to target key genes and block virus replication. We provide ready-to-use siRNA Controls and custom synthesis of siRNA Duplexes. We can assist you with the design of your sequences.

siRNA Duplexes Configure
siRNA Controls Shop Now

We provide ready-to-use mixes as well as individual reagents for end-point PCR.

Oligonucleotides Oligo Overview
PCR Mixes Select
Polymerases Select
Reverse Transcriptase Shop Now
dNTPs Select
Plates and tubes Select

For customers who prefer to synthesize by themselves their nucleic acid sequences, we distribute synthesis reagents from Glen Research company. Glen Research is a provider of critical reagents required during the COVID pandemic. As a distributor of their products in most European countries, we can help you in synthesizing high-quality oligonucleotides.

View more

SARS-CoV-2 related subjects


1) A novel coronavirus from patients with pneumonia in China, 2019.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al.
N Engl J Med. 2020;382(8):727–33 – DOI: 10.156/NEJMoa2001017

2) Genome evolution of SARS-CoV-2 and its virological characteristics.

So Nakagawa and Takayuki Miyazawa.
Inflammation and Regeneration (2020) 40:17 – DOI: 1186/s41232-020-00126-7

3) A pneumonia outbreak associated with a new coronavirus of probable bat origin.

P. Zhou, X.L. Yang, X.G. Wang, B. Hu, L. Zhang, W. Zhang, H.R. Si, Y. Zhu, B. Li, C.L. Huang, H.D. Chen, J. Chen, Y. Luo, H. Guo, R.D. Jiang, M.Q. Liu, Y. Chen, X.R. Shen, X. Wang, X.S. Zheng, K. Zhao, Q.J. Chen, F. Deng, L.L. Liu, B. Yan, F.X. Zhan, Y.Y. Wang, G.F. Xiao, Z.L. Shi.
Nature 579 (7798) (2020) 270–273 – DOI: 1038/s41586-020-2012-7

4) On the origin and continuing evolution of SARS-CoV-2.

Tang X, Wu C, Li X, Song Y, Yao X, Wu X, et al.
Natl Sci Rev. 2020 Mar 3 : nwaa036 – DOI: 1093/nsr/nwaa036

5) Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.

Barnaby E Young et al.
Vol 396, August 18, 2020 - DOI: 10.1016/ S0140-6736(20)31757-8